Florence, Italy

Anna Maria Papini

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Anna Maria Papini: Innovator in Bioactive Peptides

Introduction

Anna Maria Papini is a distinguished inventor based in Florence, Italy. She has made significant contributions to the field of bioactive peptides, focusing on their applications in cosmeceuticals and therapeutic treatments. With a total of two patents to her name, her work addresses critical issues such as skin aging and multiple sclerosis.

Latest Patents

One of her latest patents is titled "Bioactive peptides and compositions comprising them." This invention relates to bioactive peptides and cosmeceutical compositions that are useful for preventing and treating signs of skin aging, including wrinkles, fine lines, and loss of skin firmness and elasticity. The efficacy of these peptides lies in their ability to protect dermal collagen. Another notable patent is "Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis." This invention describes glycopeptides that can identify multiple sclerosis antibodies, making them valuable diagnostic tools or therapeutic agents for this condition.

Career Highlights

Anna Maria Papini has worked with esteemed institutions such as Università Degli Studi di Firenze and Espikem S.r.l. Her research and innovations have garnered attention in both academic and commercial sectors, showcasing her expertise in the field of bioactive compounds.

Collaborations

Throughout her career, Anna has collaborated with notable professionals, including Paolo Rovero and Mario Chelli. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Anna Maria Papini is a prominent figure in the realm of bioactive peptides, with her inventions paving the way for advancements in skincare and medical diagnostics. Her contributions continue to impact the fields of cosmeceuticals and therapeutic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…